
Wall Street urged Pfizer to lower its COVID revenue estimates. The company did — but it’s still betting on higher demand for its vaccine and antiviral by 2025.
What's your reaction?
Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0